Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection

Gastroenterology Clinics of North America 2026

View at publisher

Authors: Parul Berry, Jessica R. Allegretti, Sahil Khanna

DOI: 10.1016/j.gtc.2026.05.010

Cited by: 1

References: 36

Fields of Study & Subjects

Clostridium difficile and Clostridium perfringens research Gastrointestinal motility and disorders Probiotics and Fermented Foods

References 36